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ABSTRACT 
Molecular determinants of malaria pathogenesis are largely undefined. Chemokines and 
chemokine receptors, regulate immune responses, may thus determine malaria severity. Further, 
by regulating HIV pathogenesis, they may constitute a crucial link in malaria-HIV interaction. 
Understanding biologic mechanisms underlying malaria-HIV interaction has important public 
health utility in designing rational therapeutic and preventive strategies. Malaria could 
potentially modulate HIV-1 infection through alteration in expression of CD4 and chemokine 
receptors, required for cellular entry. This study has determined circulating levels and 
transcriptional profiles of β-chemokines (MIP-1α, MIP-1β, and RANTES) in ex vivo peripheral 
blood mononuclear cells (PBMCs) of children with varying degrees of malaria severity. 
Additional in vitro experiments assessed the effects of stimulation of PBMCs with crude 
hemozoin (Hz) or synthetic hemozoin (sHz) on CD4, β-chemokine and chemokine receptor 
(CCR5 and CXCR4) protein expression and transcript formation. Plasma MIP-1α and MIP-1β 
levels were significantly elevated in mild and severe malaria, while RANTES levels decreased 
with increasing disease severity. β-chemokine gene expression closely matched circulating β-
chemokine profile, illustrating that PBMCs are a primary source for β-chemokine production 
during malaria.  Healthy children with a history of severe malaria had lower baseline RANTES 
production than children with a history of mild malaria, suggesting inherent differences in 
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RANTES production. In vitro experiments in PBMCs from healthy malaria-naïve donors showed 
that Hz and sHz promote a similar pattern of β-chemokine protein secretion and transcript 
expression. FACS analysis showed that Hz and sHz induced similar patterns of cellular surface 
expression of CD4, CCR5 and CXCR4 on PBMCs. Hz or sHz-exerted differential effects on 
CD14+ and CD3+ subsets, and this modulatory effect part to transcriptional regulation based on 
gene expression profiles obtained for respective antigens. Additional studies showed that HIV-1 
replicates differently in monoctye-derived macrophages (MDMs) stimulated with either Hz or 
sHz. sHz enhanced HIV-1 replication while Hz had an inhibitory effect.  Results presented here 
demonstrate a distinct profile of β-chemokine expression in children with severe malaria, which 
is promoted by P. falciparum derived hemozoin.  Further, Hz modulates expression of surface 
antigens required for HIV-1 entry, defining a possible mechanism for HIV-malaria interaction. 
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CHAPTER 1 
1.1. General Introduction 
Malaria is a major cause of morbidity and mortality in tropical countries (1). Children less than 5 
years of age, pregnant women and nonimmune people (e.g. travelers) are at the highest risk of 
severe disease (1).  For example, the annual death toll from malaria is estimated to be one 
million children in Africa; 90% of annual global malaria mortality (1). Young children are 
especially susceptible to malaria due to their non-immune status (2).  Malaria in pregnancy 
results in anemia, low birth weight, preterm delivery and high neonatal mortality (3).  The 
etiologic agents for malaria in human are four species of protozoal parasites: Plasmodium vivax, 
Plasmodium ovale, Plasmodium malariae and Plasmodium falciparum, all transmitted by female 
Anopheline mosquitoes. Of these parasites, P. falciparum and to a lesser extent P. vivax are the 
major cause of morbidity and mortality in malaria (4).  
The life cycle of Plasmodium spp involves distinct stages in the mosquito vector and the 
human host (5). Sporozoite forms of the parasite are injected subcutaneously by mosquito vector 
during a blood meal, and the parasites rapidly migrate to the liver. Within the liver, after a period 
of dormancy (how long), the sporozoites mature in the liver hepatocytes and become merozoites 
which are released into the circulation resulting in infection of red blood cells (RBCs). Rupture 
of parasitized RBCs (pRBCs) results in the release of merozoites and expansion of the 
population into neighboring RBCs. The sexual phase of the parasites in RBCs results in male and 
female gametocytes that are ingested by the mosquito vector during a blood meal. The release of 
merozoites from ruptured RBCs corresponds with the paroxysms of fever and other clinical 
manifestations of infection.  
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From a therapeutic perspective, malaria presents enormous challenge. There is widespread 
increase in resistance to first line therapies, including chloroquine and 
sulphadoxine/pyramethamine (6). This coupled with the fact that there is yet no vaccine currently 
available (7) makes malaria a major health and socioeconomic challenge. The use of insecticide-
impregnated bed nets is widely being implemented as a prevention strategy against malaria in 
areas of high transmission (8, 9).   
Another consideration in malaria pathogenesis is the current recognition of the potential 
interaction existing between malaria and viral, bacterial and other parasitic infections. HIV 
infection and the resultant acquired immune deficiency syndrome (AIDS) represent a major co-
infection particularly in the developing countries where there is geographical overlap in the 
prevalence of malaria and HIV (10).  Approximately 40 million people are currently living with 
HIV/AIDS, and majority of these cases are the Sub-saharan Africa (11).  
HIV belongs to lentivirus subfamily of retroviruses, characterized by possession of the 
enzyme reverse transcriptase that enables replication of the single-stranded viral RNA genome 
though a double-stranded DNA intermediate (12).   Synthesized viral DNA integrates within the 
host cellular DNA as proviral sequence achieved by a virally encoded integrase enzyme, 
followed by replication using host cellular components (12). Cellular tropism for viral particles is 
defined principally by expression of CD4, and chemokine receptors (e.g. CCR5 and CXCR4) on 
the surface of host cells that serve as the primary receptor and co-receptor, respectively, for entry 
of the virus into the cells (13). An immunologic hallmark of HIV infection is the progressive 
depletion of CD4+ T helper cells, resulting in immune deficiency state that predisposes an 
individual to opportunistic infections,  and ultimately death (14). 
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In adult population, the sexual route represents the main mode of transmission of the 
virus, while in pediatric populations over 90% of infections are acquired through mother-to-child 
transmission. Currently there is no therapeutic regime that can “cure” HIV infection.  Highly 
active antiretroviral therapy (HAART) is regarded as the standard of care (15)  but is limited by 
side-effects, emergence of resistant strains, and lack of availability for much of the developing 
world  (15).  An effective vaccine against HIV remains elusive (16), illustrating that an improved 
understanding the basic biology of the virus and possible interactions with other infections 
remains critical for efforts aimed at designing effective therapies and vaccine strategies against 
HIV.  
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CHAPTER 2 
2.1 Chemokines as Mediators of Malaria Pathogenesis 
2.1.1 Determinants of Malaria Disease Severity  
Malaria is one of the greatest influences of infectious origin on morbidity and mortality in sub-
Saharan Africa (1). In young children who are largely non- or semi-immune to Plasmodium 
falciparum malaria, severe disease primarily manifests as cerebral malaria (CM) and/or severe 
malarial anemia (SMA) (17). In areas of hyperendemicity, such as Lambaréné, Gabon, severe 
malaria generally affects children less than 5 years of age due to the lack of naturally acquired 
immunity (2). The primary clinical manifestations of severe malaria in this area are SMA and 
high-density parasitemia with only rare occurrences of CM.  
 Although the molecular determinants of mild versus severe malaria are largely undefined, 
current evidence suggests a potential role for the relative balance between pro- and anti-
inflammatory cytokines (18-22).   Elevated levels of pro-inflammatory cytokines during the 
acute phase of infection appear to limit disease progression, while a bias towards an anti-
inflammatory response appears to promote increased pathogenesis (21, 23-25). Additional 
soluble inflammatory mediators which may be important in malaria pathogenesis are 
chemokines, a superfamily of small structurally related proteins (8-17 kDa) that regulate innate 
and adaptive immunity (26).   
 
2.1.2. Chemokine Nomenclature and Biological Function 
Chemokines are categorized into four classes based on the number and spacing of N-terminal 
cysteine residues (27).  These classes can be more broadly defined as   CXC- (or α-) chemokines 
[e.g. stromal cell derived factor (SDF)-1] and the CC- (or β-) chemokines [e.g. macrophage 
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inflammatory protein (MIP-1α), MIP-1β, and Regulated on Activation, Normal T-cell Expressed 
and Secreted (RANTES)] (27).  The actions of chemokines are mediated by a family of 7-
transmembrane G protein-coupled receptors (26).  Binding of chemokines to their cognate 
receptors results in an intracellular signaling cascade that culminates in diverse biological 
functions, such as chemotactic recruitment of inflammatory cells, leukocyte activation, 
angiogenesis, hematopoiesis, and antimicrobial effects (26).  
In addition to their role in regulating the immune response during viral and bacterial 
infections, chemokines also appear to mediate the host-immune response during protozoan 
infections (28).  For example, recent studies have shown that P. falciparum during pregnancy is 
characterized by elevations in MIP-1α, monocyte chemoattractant protein (MCP)-1, I-309, and 
interleukin (IL)-8 transcripts which are associated with increased monocyte density in the 
placental intervillous space (29, 30).  Additional studies in women with malaria during 
pregnancy show that MIP-1α and MIP-1β are elevated in cultured intervillous leukocytes (31). 
Serum concentrations of MIP-1α and interleukin (IL)-8 are also increased in adults with severe 
and complicated falciparum malaria (32). 
 
2.1.3. Hemozoin (Hz) Synthesis and Function 
Recent studies in our laboratory found that malarial pigment (hemozoin, Hz) is one of the 
parasitic products responsible for regulating the production of effector molecules, such as nitric 
oxide (NO) and prostaglandin-E2 (PGE2) from peripheral blood mononuclear cells (PBMCs) 
during acute falciparum malaria in children (33, 34).  Hz is a coordinated aggregation polymer of 
heme produced by parasites within red blood cells (RBCs) during the digestion of host 
hemoglobin [for review see (35)].  Following lysis of parasitized RBC, Hz is rapidly 
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phagocytosed by neutrophils, monocytes, and tissue macrophages.  Naturally acquired Hz is 
composed of host- and parasite-derived lipids, proteins, and nucleic acids which are associated 
with the polymerized iron core structure, ferriprotoporphorin (FP)-IX (36).  Upon removal of 
proteins and lipids from Hz, the FP-IX core remains, which is structurally identical to synthetic 
pigment, β-hematin (sHz) (37).  Our laboratory, as well as others, have shown that Hz and sHz 
promote similar patterns of pro- and anti-inflammatory cytokines, effector molecules, and 
chemokines, such as IL-1β, TNF-α, IL-10, NO, PGE2, MIP-1α, and MIP-1β from cultured 
human PBMCs as those observed in children with malaria (33, 34, 38, 39).  Hz is a key molecule 
that mediates malaria-associated immunosuppression (40), and its phagocytosis by monocytes 
alters expression of MHC class II, CD54 and CD11c which may result in impairment of antigen 
presentation (41).  Recent evidence in murine model of malaria indicates that in vivo 
administration of hemozoin rapidly up regulates chemokines and chemokine receptor expression, 
and this effect is associated with increased cellular infiltration (42). 
Although chemokines are important for bridging innate and adaptive immune responses 
and regulating hematopoietic maturation (43, 44), the profile of chemokine expression and their 
potential role in regulating disease severity in children with P. falciparum malaria has not been 
defined.  As such, we determined circulating protein levels and transcript profiles of β-
chemokines (MIP-1α, MIP-1β and RANTES) and an α-chemokine (SDF-1) in plasma and 
PBMCs, respectively, in children with varying degrees of P. falciparum malaria.  Additional 
studies were conducted in cultured PBMCs to determine if Hz and sHz induced a similar profile 
of chemokine transcripts and protein as that found in children with malaria.    
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2.2 Malaria and HIV Interaction 
2.2.1 Epidemiological Evidence 
It is becoming increasingly apparent that subtle interactions exist between infectious pathogens, 
and that a full understanding of any given infection process can only be achieved if potential 
specific interactions with other infectious agents are elucidated. Human immunodeficiency virus 
(HIV) infection and Plasmodium falciparum-induced malaria are both associated with high 
morbidity and mortality, particularly in the developing countries (11, 45).  With regards to global 
prevalence, considerable geographical overlap between malaria and HIV-1 infection suggests 
possible interaction between these infections (10). Approximately 40 million people are living 
with HIV/AIDS, with over 70% in Sub-saharan Africa (11). Malaria accounts for approximately 
1-3 million deaths annually, with over 90% of the 300-500 annually reported infections 
occurring in Sub-saharan Africa (2, 46). Understanding interaction between HIV and malaria, 
thus, has enormous public health importance, particularly in the context of designing effective 
intervention strategies in populations where HIV and malaria are prevalent.  
Early epidemiological studies showed lack of association between HIV and malaria (47-
49). These studies were, however, limited in design and technical capability to assess immune 
compromise accurately by the use of CD4 counts and HIV-1 viral loads. Recent evidence, 
however, supports potential reciprocal interaction between HIV-1 and malaria. Advanced HIV 
immunosuppression is associated with higher density parasitemia and more clinical illness in 
adults (50-53). These findings have further been supported by additional observational studies in 
cohorts of pregnant women, indicating that HIV infection results in increased prevalence of 
placental malaria (54-56). The underlying mechanism-based explanation for increased frequency 
of placental malaria in HIV-coinfected women is presently unknown with conflicting evidence 
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regarding the role of the humoral immune response (57, 58), and limited data on cellular immune 
response in these women (59). Interestingly, studies in pediatric populations are inconclusive on 
the effect of HIV infection on the clinical course of malaria (60, 61). Conversely, malaria has 
been shown to impact on the clinical course of HIV infection. Acute P. falciparum infection is 
associated with increased HIV-1 viral loads in non-pregnant (62) and pregnant (63-65) adult 
populations. However, in spite of demonstrable increases in placental viral loads in women with 
malaria, the effect of this process on mother-to-child transmission is not clearly defined (64, 66, 
67).  
 
2.2.3. Potential Mechanism (s) of Interaction 
Despite these numerous epidemiological studies supporting evidence for malaria-HIV 
interactions, there is limited data on potential biological mechanisms that define the interaction. 
Previous studies by Xiao and colleagues (68) showed that increased cellular activation, mediated 
by TNF-α, and induced by malarial antigen stimulation resulted in enhanced HIV-1 replication 
in human mononuclear cells.  Cellular activation as a mechanism for malaria-induced HIV 
replication has further been supported by data generated in vitro model (69), transgenic mice 
model (70) and clinical settings (71). The latter study showed that parasite clearance achieved 
with antimalarial therapy results in decreased in HIV-1 particles derived from macrophages as a 
consequence of diminution in systemic immune activation.  
An additional mechanism through which malaria could influence HIV pathogenesis is by 
modulation of receptors required viral entry and in vivo dissemination. HIV-1 entry into 
susceptible cells is mediated by interactions with CD4 and chemokine receptors which serve as 
primary and co-receptors, respectively (72). Chemokine and chemokine receptors belong to a 
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superfamily of proteins, whose principal role involves leukocyte chemotaxis (73). HIV-1 
interacts with CCR5 and CXCR4 via gp120, specifically its V3 loop, which determines cellular 
tropism (74, 75). On the basis of chemokine receptor utilization, HIV-1 strains have been 
categorized as R5, X4 or R5-X4, corresponding to macrophage tropic, T cell tropic, or dual 
tropic, respectively (13). Evolution of X4 viruses is associated with progression to clinical end-
stage disease (76-78). Investigating the effects of malaria on chemokine and chemokine receptor 
expression is therefore critical in understanding the initial establishment of HIV-1 infection of 
susceptible cells, and the clinical progression of disease through alterations in the proportion of 
in vivo cellular targets.  A recent study has shown that soluble malarial antigens regulate 
expression of CCR5 and CXCR4 on human CD4+ mononuclear cells (79). 
To determine potential mechanisms by which malaria affects HIV-1 infection, this study 
utilized an in vitro model based on stimulation of human peripheral blood mononuclear cells 
(PBMCs) with crude plasmodium falciparum-derived pigment, hemozoin (Hz), or its synthetic 
form (sHz). The present study has analyzed surface expression of CD4, CCR5 and CXCR4, and 
quantitated the respective transcripts by real time RT-PCR. In addition, susceptibility of 
monocyte-derived macrophages (MDMs) stimulated with either Hz or sHz was determined 
following infection with M-tropic HIV-1.   
 
2.3 Purpose 
These studies were conducted to define the profile of β-chemokines in children with acute P. 
falciparum infection, and to determine association between β-Chemokine profile and malaria 
severity. Additional experiments were designed to define molecular basis of interaction between 
malaria and HIV. Surface expression and transcript formation of antigens required for HIV-1 
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entry were analyzed following stimulation of PBMCs with Hz or sHz to determine if this results 
in altered infectivity of human mononuclear cells with HIV-1.   
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CHAPTER 3
3.1 Materials and Methods 
3.1.1 Study Participants 
Children (n=43, age 2 to 7 years) were recruited from a longitudinal prospective study at the 
Albert Schweitzer Hospital in Lambaréné, Gabon in the Province of Moyen Ogooue.  In this 
hyperendemic area of malaria transmission, the primary clinical manifestation of severe 
childhood malaria is severe anemia and/or hyperparasitemia, with cerebral malaria rarely 
occurring (18, 80).  Classification of malaria was defined according to our previously published 
methods (81) with inclusion criteria for severe cases characterized by parasitemias greater than 
250,000 parasites/µL and/or the presence of severe anemia (i.e. hemoglobin ≤ 5 g/dL) (81).  
Matched mild malaria cases were defined by parasitemias less than 100,000 parasites/µL and the 
absence of any signs or symptoms of severe malaria.  Healthy, malaria-exposed subjects were 
defined as those participants with a previous episode(s) of either mild or severe malaria and the 
absence of a positive thick blood film for malaria, or any other illnesses, within the last 4 weeks.  
All blood samples were obtained prior to treatment with antimalarials and/or antipyretics.  
Routine clinical evaluations and laboratory measures were used to evaluate the patients.  
Children with malaria were given antimalarials and the appropriate supportive therapy as 
required.  Informed consent was obtained from the parents of participating children.    
 For in vitro experiments to determine the effect of Hz or sHz on production of β-
chemokines, healthy malaria-naïve adult volunteers (n=5) were recruited at the University of 
Pittsburgh, US.  The study was approved by the ethics committee of the International Foundation 
of the Albert Schweitzer Hospital, Duke University Medical Center Investigational Review 
Board, and the University of Pittsburgh Investigational Review Board.   
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3.1.2. Isolation and Culture of Peripheral Blood Mononuclear Cells (PBMCs) 
Venous blood (50 mL) was drawn from healthy adult US donors into EDTA-containing vials.  
Plasma was separated and PBMCs were prepared using Ficoll/Hypaque according to previous 
methods (82). PBMCs collected from the interface were subsequently washed twice with 
Dulbecco’s Modified Eagles Medium (DMEM) [Invitrogen Corporation, Carlsbad, CA] 
supplemented with 10mM HEPES, 10mM Penicillin/Streptomycin).  
To assess the effects of Hz or sHz on the production of chemokines, PBMCs were plated 
at a density of 1 Χ 106 cells/mL in DMEM supplemented with 10mM HEPES, 10mM 
Penicillin/Streptomycin, and 10% pooled human serum (heat inactivated at 56oC for 30 min).  
Cells were incubated with media alone (control) or physiologic amounts of Hz or sHz 
representing a concentration comparable to that during severe malaria (i.e., 10 µg/mL) (33).  
Cells were kept at 37oC in a humid atmosphere of 5% CO2.  Supernatants and cell pellets were 
collected at 4, 24, 48 and 120 hr.  
 
3.1.3. Preparation of Crude Hemozoin and Synthetic Hemozoin 
Protocols for preparation of crude Hz and sHz have been described previously (34).  In brief, Hz 
was derived from in vitro cell cultures of P. falciparum-infected red blood cells (strain Pf-D6) 
harvested when the parasitemia level was 3 to 5%, and late trophozoites and early schizonts were 
the predominant forms. Infected RBCs were spun at 2,000 rpm for 10 min, and re-suspended in 
40 mL of 0.01 M phosphate-buffered saline (pH 7.2) with 2 mL of 1% saponin solution for 10 
min.  Cell lysates were then subjected to ultracentrifugation (14,000 rpm for 15 min) and 
resultant cell pellets were washed 3 to 5 times to remove lipid membranes.  Following the final 
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wash step, the pellet was dried overnight, weighed, and re-suspended in filter-sterilized H2O at a 
concentration of 1.0 mg/mL. 
 sHz was prepared in a 4.5 M acidic acetate solution (pH 4.5) as previously described 
(37).  In brief, hemin chloride (Sigma, St. Lous, MO) was added to a 0.1 M solution of NaOH 
followed by addition of HCl at 60oC.  sHz was crystallized by addition of an acidic solution of 
acetate and the mixture was incubated at 60oC for 150 min.  The solution was then centrifuged 
and washed thrice with distilled (dH2O), and dried at 60oC under vacuum.  The final pellet was 
weighed and re-suspended in filter-sterilized H2O at a concentration of 1.0 mg/mL. 
 
3.1.4. Chemokine ELISAs   
Quantitative ELISA was performed with commercially available assays to determine MIP-1α, 
MIP-1β, and RANTES (Biosource International, Camarillo, CA) and SDF-1 (DuoSet: R&D 
Minneapolis, MN) levels in plasma or culture supernatants.  The standard deviation (SD) of 
replicate samples was less than 10% of the mean in all experiments.  Sample concentrations of 
each chemokine were quantified from standard curves generated with recombinant chemokines 
and analyzed with Softmax Software (Molecular Devices Corporation, Sunnyvale, CA). The 
lower limit of detection for the chemokines analyzed was 15 pg/ml. 
 
3.1.5. Quantitative Real Time RT-PCR   
Total RNA was extracted from PBMCs by the GITC method (83).  Following isopropanol 
precipitation, RNA was pelleted at 13,000 rpm for 15 min and resuspended in RNase-free water 
to a final concentration of 1.0 µg/µL.  Extracted RNA (1.0 µg) was reverse transcribed using 
random primers to generate cDNA.   One-tenth (2.0 µl) of the resulting cDNA was then used as a 
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template for Taqman real time PCR amplification on an ABI Prism 7700 Sequence Detection 
System (Applied Biosystems, Foster City, CA).  Each PCR reaction was set up in duplicate with 
2.0 µl of cDNA template in a total volume of 25 µl comprised of Taqman®Universal Master 
Mix, and specific primer/probe sets for chemokine transcripts: MIP-1α (Hs00234142_mL), MIP-
1β (Hs00605740_mL), RANTES (Hs00174575_mL), SDF-1 (Hs00171022_mL), CCR5 
(Hs00152917_ml) and CD4 (Hs00181217_ml) (Applied Biosystems, Foster City, CA). 
Transcripts for CXCR4 were analyzed using previously described primer-probe sets (84). 
Amplification of β-actin {Accession Number NM_001101 (Applied Biosystems, Foster City, 
CA)} served as an endogenous control to normalize loading of cDNA samples.  For experiments 
in ex vivo PBMC from Gabonese children, data were compared by subtracting the β-actin cycle 
threshold (CT) value from the experimental gene CT for each sample, and expressed as fold-
change relative to β-actin levels (2-∆CT).  For experiments in cultured PBMCs, data were 
compared using the -∆∆CT method as previously described (33).  
 
3.1.6. Flow Cytometry Analyses 
Expression of surface antigens on PBMC determined by a three-color FACS analysis with the 
antibody panels shown in Table 2. All the monoclonal antibodies were purchased from BD 
Biosciences–Pharmingen, (San Diego CA). Cells were incubated with the mAb for 30 min at 
4oC, washed twice, and then fixed in 1% paraformaldehyde solution and analyzed on a Coulter 
EPICS XL Flow Cytometer (Coulter Corporation). Matched isotype antibody controls; 
Flourescein Isothyanate (FITC)-labeled mouse IgG1 (FITC) (clone: MOPC-21), Phycoerythrin 
(PE)-labeled mouse IgG2b (Clone: 27-35) and Phycoerythrin-Cytochrome 5 (PE-Cy5)-labeled 
mouse IgG2a (clone: G155-178) were used to control for non-specific binding. Acquired data 
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were analyzed with Summit® Software version 3.1 (DakoCytomation, Fort Collins, CO) to 
determine expression of CD4, CCR5 and CXCR4 on CD14+ and CD3+ cell subsets. Data were 
presented as percent expression of CD4, CCR5 or CXCR4 on CD14+ monocytes or CD3+ 
lymphocyte populations, and plotted as relative expression (mean ± s.e.m) between cells 
stimulated with either Hz or sHz and unstimulated control cells.  
 
3.1.7. HIV-1 Infection of Monoctye-derived Macrophages (MDMs) 
To determine differences in susceptibility of MDMs stimulated with Hz or sHz to HIV-1 
infection, human monocytes were isolated from buffy coats of HIV-seronegative healthy adult 
blood donors (University of Pittsburgh, USA) by Ficoll/Hypaque density gradient centrifugation 
and positive isolation with CD14 MicroBeads (Milteny Biotec Inc, Auburn, CA).  CD14+ 
enriched monocytes were plated at a density of 1 Χ 106 cells/mL in DMEM supplemented with 
10mM HEPES, 10mM Penicillin/Streptomycin, and 10% pooled human serum (heat inactivated 
at 56oC for 30 min).  Cells were incubated with media alone (control) or physiologic amounts of 
Hz or sHz as described above for PBMCs. Cells were then cultured for 7 days in media 
containing 10ng/mL granulocyte-macrophage-colony stimulating factor (GM-CSF; R&D 
Systems, Minneapolis, MN), and then exposed to M-tropic HIV-1BAL (AIDS Research and 
Reference, MD) (MOI = 0.1) for 2 hr. To determine whether the effect of Hz or sHz was through 
soluble factors released upon cellular stimulation with malarial pigment versus a direct effect of 
malarial pigment, culture supernatants (conditioned medium) were harvested from unstimulated 
control cells, and Hz-or sHz-stimulated cells and used in parallel infections at 1:1 dilution with 
fresh medium. Unbound virus was washed three times, and cells were kept at 37oC in a humid 
atmosphere of 5% CO2 for an additional 5 days.  Supernatants were harvested from the cultures 
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at days 0, 3 and 5 post-infection and analyzed for p24 using commercial ELISA (NENTM Life 
Science Products, Boston, MA) with a detection limit of 26 pg/mL.   
 
3.1.8. Statistical Analyses 
Mann-Whitney U tests (statistical significance set at p < 0.05) were used to analyze for 
differences in concentration of chemokines in plasma and chemokine gene expression profiles 
between groups, and Pearson correlations were conducted to examine the linear associations 
among the variables of interest. For in vitro experiments with human PBMCs, chemokine 
concentrations in culture supernatants and gene expression were analyzed for statistical 
significance between Hz- or sHz-stimulated cells and unstimulated control cells using Mann-
Whitney U tests (p < 0.05). Similarly, surface expression of CD4, CCR5 and CXCR4 on 
monocytes and lymphocyte subpopulations and gene expression were analyzed for statistical 
significance between Hz- or sHz-stimulated cells and unstimulated control cells using Mann-
Whitney U tests (p < 0.05). 
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CHAPTER 4 
4.0. Results 
4.1.  β-chemokine profile in children with malaria  
4.1.1. Circulating levels of chemokines in children with malaria  
To quantify circulating levels of β-chemokines, plasma samples were obtained from children 
with varying degrees of malaria disease; healthy controls (HC, n = 23), mild malaria (MM, n = 
10) and severe malaria (SM, n = 10), and analyzed by ELISA.  MIP-1α was largely undetectable 
in the plasma of the HC group, but was elevated in children with MM (p < 0.01) and SM (p < 
0.01, Fig. 1A).  Similarly, levels of MIP-1β were higher in children with MM (p < 0.01) and SM 
(p < 0.01) compared to HC (Fig. 1B).   Although the SM group had higher levels of MIP-1α and 
MIP-1β than the MM group, levels were not significantly different between the groups.  In 
contrast to MIP-1α and MIP-1β, circulating levels of RANTES were lower in children with SM 
compared to HC (p < 0.01, Fig. 1C).  Although median RANTES levels were lower in plasma of 
children with MM relative to HC, the difference was not statistically significant, but were, 
however, significantly higher than in children with SM (p < 0.05).  Additional experiments 
revealed that plasma SDF-1 was not detectable in any of the children in the present study (data 
not shown) 
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Figure 1. Plasma Levels of Chemokines in Children with Malaria.  
β-chemokines (MIP-1α, MIP-1β and RANTES) and α-chemokine (SDF-1) levels were determined in plasma of 
healthy children (HC, n=23), those with mild malaria (MM, n=10), and severe malaria (SM, n=10) with commercial 
ELISA. Each box plot represents the range (25th -75th percentiles) chemokine concentration for each category, with 
the median value at the intersect. MIP-1α (A) and MIP-1-β (B) were significantly elevated in plasma of children 
with MM and SM compared to HC (p < 0.001). Children with SM had significantly lower plasma levels of 
RANTES than HC (p < 0.01) (C). Levels of RANTES in children with MM, though lower compared to HC were not 
significantly different (p > 0.05) but were significantly higher than in children with SM (p < 0.05).  
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4.1.2 β-Chemokine Transcript Profiles 
To determine the potential cellular source(s) of circulating chemokines, gene expression profiles 
for MIP-1α , MIP-1β,  and RANTES were determined by Taqman real time RT-PCR in ex vivo 
PBMCs isolated from children with varying degrees of malaria.  Relative to HC, MIP-1α 
expression was significantly increased in children with either MM (p < 0.05) or SM (p < 0.05, 
Fig. 2A).  Similarly, MIP-1β gene expression was significantly elevated in children with MM 
and SM compared to HC (p < 0.05, Fig. 2B).  In contrast, RANTES was decreased in children 
with SM (p < 0.05), and slightly lower in children with MM (p > 0.05, Fig. 2C).  SDF-1 
transcripts were not detectable in any of the specimens analyzed (data not presented).   
 
4.1.3. Association of ß-chemokine Expression with Prior Disease Severity 
Since the history of prior malaria exposure was available for children in the HC group, data were 
further stratified into those children with previous mild malaria (PMM, n = 13) and those with 
previous severe malaria (PSM, n = 10).  These groups were analyzed for circulating levels of 
RANTES and transcript levels in ex vivo PBMCs.  As shown in Fig. 3A, the PMM group had 
significantly higher plasma RANTES levels than the PSM group (p < 0.05).  RANTES 
transcripts were significantly lower in children with PMM than those with PSM (p < 0.01 Fig. 
3B).  Levels of MIP-1α and MIP-1β protein and transcripts were not significantly different 
between the PMM and PSM groups (data not shown).  
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Figure 2. Transcriptional Profiles of Chemokines in Children with Malaria. 
MIP-1α, MIP-1β, RANTES and SDF-1 mRNA expression was determined by real time RT-PCR on cDNA isolated 
from PBMC of healthy children (HC, n=23), those with mild malaria (MM, n=10) and severe malaria (SM, n=10). 
Gene expression for each chemokine is presented relative to expression of endogenous β-actin.  MIP-1α (A) and 
MIP-1β mRNA levels (B) were significantly higher in children with MM and SM compared to HC (p < 0.05). 
RANTES mRNA levels were significantly lower in children with SM compared to HC (C) (p < 0.05). Similarly, 
among malaria cases, children with SM had significantly lower expression of RANTES mRNA compared to patients 
with MM (p < 0.05). SDF-1 transcripts were not detectable in any of the specimens analyzed.  
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Figure 3. Circulating RANTES and ex vivo PBMC mRNA Levels in Healthy Children with 
Prior Malaria Exposure. 
RANTES levels in healthy children (HC) with a history of either mild malaria (PMM, n =14) or severe malaria 
(PSM, n = 9) were determined in plasma by commercial sandwich antibody ELISA, and gene expression profiles 
were determined by real time RT-PCR on RNA isolated from PBMC (expressed relative to endogenous β-actin). 
The PSM group had significantly lower plasma RANTES levels than the PMM group (p < 0.05) (A). In contrast, 
RANTES mRNA levels were significantly higher in PSM compared to PMM cases (p < 0.01) (B). MIP-1α and 
MIP-1β plasma levels and gene transcripts were not significantly different in either PMM or PSM children (data not 
presented). ** indicates statistical significance; p < 0.01, and * indicates statistical significance; p < 0.05 compared 
to controls.  
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 4.1.4. Association of β-chemokines with Hemoglobin Concentrations and Parasite Density 
To examine the linear associations between the chemokines and clinical parameters (i.e., anemia 
and parasitemia), bivariate Pearson correlations were conducted.  These correlations were 
performed on the mild and severe malaria groups only (n = 29) due to the fact that hemoglobin 
measurements were not obtained from the healthy control group.  Before conducting the 
analyses, all relevant variables were examined for departures from normality.  Since MIP-1α and 
parasitemia were moderately positively skewed, these variables were normalized by square-root 
transformations prior to performing the analyses. Although there was a significant negative 
correlation between parasitemia and hemoglobin (r = -.402, p = .047), none of the other 
correlations were statistically significant (Table 1).  As a follow-up to the correlation analyses, 
we conducted two linear multiple regression analyses on the mild and severe malaria groups, one 
each for the dependent variables of hemoglobin and parasitemia. The purpose of these analyses 
was to examine the unique predictive ability of each of the three chemokines (i.e., MIP-1α, MIP-
1β and RANTES) after controlling for the remaining two chemokines and age. Both of the 
regression equations were statistically nonsignificant and, likewise, all of the standardized partial 
regression coefficients (β weights) were nonsignificant, indicating that none of the chemokines 
uniquely predicted anemia and parasitemia.    
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Table 1. Correlation between β-chemokines, hemoglobin, and parasitemia. 
 ra p rb p 
Age 0.105 NS -0.297 NS 
MIP-1α 0.148 NS 0.033 NS 
MIP-1β -0.316 NS 0.230 NS 
RANTES 0.062 NS -0.309 NS 
 Table shows Pearson correlation coefficients (mild and severe malaria groups only). ra = 
Hemoglobin, rb = Parasitemia. NS = Not significant 
 
4.1.5. Effect of Hz and sHz on PBMC Chemokine Production 
Previous studies reported that parasite-derived products, such as Hz, can augment production of 
MIP-1α and MIP-1β from cultured human PBMCs (38).  Results presented here show that β-
chemokine levels were higher in children with severe malaria, and we have previously shown 
that children in this population with severe malaria have significantly higher circulating levels of 
Hz-containing monocytes and neutrophils than children with mild malaria (85).  Therefore, to 
determine the effects of malaria pigment on β-chemokine production, PBMCs were isolated 
from healthy, malaria-naïve adult donors (n = 5) followed by culture with media alone (controls), 
Hz (10 µg/mL), or sHz (10 µg/mL).  β-chemokine concentrations were determined in culture 
supernatants at 4, 24, 48 and 120 hr.  MIP-1α and MIP-1β levels were undetectable in control 
conditions.  However, addition of Hz or sHz increased MIP-1α and MIP-1β production by 24 hr, 
and this was sustained throughout the time-course (p < 0.01 for both chemokines at 24 and 48 hr, 
Fig. 4).  Baseline RANTES production significantly decreased at 48 hr in control cells (p < 0.05, 
Fig. 4C).  SDF-1 was undetectable in culture supernatants from stimulated and unstimulated cells 
(data not shown). 
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To determine if alterations in β-chemokine production by Hz and sHz were regulated at 
the transcriptional level, gene expression profiles for MIP-1α, MIP-1β, RANTES, and SDF-1 
were determined by real time RT-PCR.  Relative to non-stimulated control PBMCs, MIP-1α and 
MIP-1β expression was significantly increased by Hz and sHz at 4, 24, and 48 hr (p < 0.05, Fig. 
5).  In contrast, RANTES expression was not altered by either Hz or sHz at 4 hr (Fig. 5C). After 
24 hr in culture, PBMCs stimulated with sHz had comparatively higher expression of RANTES 
relative to controls (p < 0.05, Fig. 5C).  RANTES gene expression in PBMCs stimulated with Hz 
for 48 hr was not significantly altered, while cells stimulated with sHz had suppression of 
RANTES mRNA expression (p < 0.05, Fig. 5C). SDF-1 transcripts were undetectable in culture 
supernatants from stimulated and unstimulated cells at all time points (data not shown). 
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Figure 4. Effects of P. falciparum-derived and Synthetic Hemozoin on Production of Chemokines by 
PBMCs.  
To determine in vitro production of chemokines by cultured human mononuclear cells, PBMCs (2 Χ 106/well) 
isolated from healthy adult volunteers (n=5) were cultured with either Hz (10 µg/mL) or sHz (10 µg/mL) for 4, 24 
and 48 hr. Cell culture supernatants harvested at each time point were analyzed by commercial sandwich antibody 
ELISA for MIP-1α (A), MIP-1β (B) and RANTES (C). SDF-1 was undetectable in supernatants analyzed.    
(unstimulated controls),         (Hz) and     (sHz)** indicates statistical significance; p < 0.01, and * indicates 
statistical significance; p < 0.05 compared to non-stimulated controls. 
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ffects of P. falciparum-derived and Synthetic Hemozoin on Chemokine Gene Expression by 
temporal profile of expression of chemokine genes, PBMCs (2 Χ 106/well) isolated from healthy adult 
 5) were cultured with either Hz (10 µg/mL) or sHz (10 µg/mL) for 4, 24 and 48 hr. Unstimulated 
 negative controls. Gene expression profile for MIP-1α (A), MIP-1β (B) and RANTES (C) RNA was 
 real time RT-PCR using specific primer/probe sets on cDNA generated from the PBMC RNA. Data 
s fold change in gene expression in stimulated cells relative to unstimulated controls.     (unstimulated 
Hz)  and      (sHz). Transcripts for SDF-1 were not detectable. ** indicates statistical significance; p < 
icates statistical significance; p < 0.05 compared to non-stimulated controls. 
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 4.2. Modulation of CD4, and Chemokine Receptors Expression on Human Mononuclear 
Cells by Hemozoin 
4.2.1. Surface Expression of CD4, CCR5, and CXCR4 on PBMCs 
To determine the pattern of surface expression of CD4, CCR5 and CXCR4 on PBMCs 
stimulated with either Hz or sHz, three-color FACS analysis was performed and the percent 
expression of these antigens was analyzed on CD14+ monoctye (Figure 6) and CD3+ lymphocyte 
(Figure 7) subsets separated based on lineage marker-specific gating.  Results were presented as 
relative expression compared to unstimulated controls.  Hz stimulation significantly up-regulated 
the expression of CD4 on monocytes at 4 and 48 hr in culture (p < 0.05) (Figure 6A). CD4 
expression was also significantly up-regulated on monocytes at 48 hr with sHz stimulation. 
Conversely, by 120 hr of culture, Hz and sHz significantly down-regulated CD4 expression on 
monocytes. CCR5 and CXCR4 were significantly down-regulated by 24 hr in Hz or sHz 
stimulated cells (p < 0.01) (Figure 6B and 6C, respectively). However, these molecules were up-
regulated on monocytes by 120 hr, with significant effects observed on sHz-stimulated cells (p < 
0.05). There were no significant differences in the expression of CD4 on CD3+ lymphocytes 
under control conditions, or following treatment with Hz and sHz (Figure 7A). In contrast, Hz 
and sHz up-regulated the expression of CXCR4 on CD3+ cells at 4 and 24 hr (Figure 7B). CCR5 
expression was undetectable (<1%) in lymphocytes (data not presented).  
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Table 2. Monoclonal Antibodies And Three-Color Flow Cytometry Panels 
 
Antibody Panels 
FITC PE PE-Cy5 (PCP) 
CD4 (RPA-T4) CD14 (MφP9) CCR5 (2D7) 
CD4 (RPA-T4) CD14(MφP9) CXCR4 (12G5) 
CD4 (RPA-T4) CD3 (HIT3a) CCR5 (2D7) 
CD4 (RPA-T4) CD3 (HIT3a) CXCR4 (12G5) 
Ms IgG1 (MOPC-21) Ms IgG2b (27-35) Ms IgG2a (G155-178) 
 
 
 
 
 
 
 
 
 
Table shows the various monoclonal antibodies used for analysis of surface antigen expression in a 
three-color FACS scheme. Isotype matched mouse (Ms) mAb were used to control for non-specific 
binding. The mAb clones are indicated in parenthesis.   
 
4.2.2. CD4, CCR5 and CXCR4 Transcript Profiles 
To determine if the observed modulation of surface expression of these receptors was due 
to transcriptional changes induced by Hz or sHz, real time RT-PCR was performed to quantitate 
mRNA for CD4, CCR5 and CXCR4 in control, Hz or sHz stimulated PBMCs (Figure 8). CD4 
expression was significantly up-regulated by both Hz and sHz at 4 hr of culture, and was 
significantly down-regulated at 48 and 120 hr (Figure 8A). CCR5 expression was significantly 
up-regulated by sHz at 24, 48 and 120 hr (p<0.05), and by Hz at 48 and 120 hr (p < 0.05) (Figure 
8B). CXCR4 expression was significantly up-regulated by Hz at 24 and 120 hr (p<0.05) (Figure 
8C). 
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Figure 6. Analysis of Surface Expression of CD4, CCR5 and CXCR4 on Monocytes. 
Pattern of surface expression of CD4, CCR5 and CXCR4 on CD14+ monocyte subsets of PBMCs.  PBMCs from 
healthy adult donors (n=5) were cultured for 4, 24 48, and 120 hr with Hz (10µg/ml) or sHz (10µg/ml). Non-
stimulated cells served as control. Cells were subsequently stained for surface markers using three-color FACS 
scheme. Expression on monocyte subsets were delineated by lineage-specific gating set on CD14+ cells.   Data are 
presented as percent expression of CD4 (A), CCR5 (B) or CXCR4 (C) on CD14+ monocytes and plotted as relative 
expression between cells stimulated with either Hz or sHz and unstimulated control cells. ** indicates statistical 
significance; p < 0.01, and * indicates statistical significance; p < 0.05 compared to non-stimulated controls. 
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 4.2.3. HIV-1 Infectivity of MDMs 
To determine whether Hz- or sHz-induced changes of CD4, CCR5 and CXCR4 influences 
susceptibility to infection with HIV-1, MDMs were infected with M-tropic HIV-1 following 
stimulation with either Hz or sHz for seven days. Infection was performed in the presence and 
absence of conditioned medium obtained from culture supernatants to determine if there were 
soluble factors induced by malarial pigment and/or direct effects of malarial pigment on viral 
replication.  In a representative experiment shown in Table 2, sHz enhanced HIV-1 replication in 
MDMs by day 3 and 5 post-infection compared to unstimulated control cells. In contrast, viral 
replication in cell cultures stimulated with Hz was comparatively lower than that of control cells. 
Treatment of the cells with a 1:1 dilution of the conditioned medium had an inhibitory effect on 
effect on HIV-1 replication (Table 3). 
Table 3 HIV-1 Infectivity of Monocyte-Derived Macrophages (MDMs) 
 Duration post-infection (days)  and p24 levels (pg/mL) 
Treatment Conditioned medium (-) Conditioned medium (+) 
 0 3 5 0 3 5 
Control  <limit* 142 21,985 <limit 92 1,084 
Hemozoin (Hz) <limit 131 3,884 <limit 98 241 
Synthetic hemozoin 
(sHz) 
<limit 589 202,903 <limit 247 1,197 
 
To determine the effect of malarial pigment on HIV-1 replication, monocyte-derived macrophages, cultured in the 
absence (control) or presence of Hz (10µg/mL) or sHz (10 µg/mL) for seven days, were exposed to M-tropic HIV-1BAL 
(MOI=0.1) for 2 hr. Infected cells were cultured for an additional five days either in fresh medium or medium 
containing a 1:1 dilution of culture supernatant harvested from control, Hz- or sHz-stimulated cells (i.e. conditioned 
medium). HIV-1 p24 antigen concentrations were determined in culture supernatants at days 0, 3 and 5 with a 
commercial ELISA. * Indicates levels below the assay detection limit (26 pg/mL) 
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Figure 8. Expression of CD4, CCR5 and CXCR4 Transcripts in PBMCs.  
Temporal profile of expression of mRNA transcripts for CD4 (A), CCR5 (B) and CXCR4 (C) determined in PBMCs 
from healthy adult volunteers (n=5) cultured either Hz (10 µg/mL) or sHz (10 µg/mL) for 4, 24, 48, and 120 hr. 
Unstimulated cells served as negative controls. Gene expression profiles were determined by real time RT-PCR 
using specific primer/probe sets on cDNA generated from the PBMCs RNA. Data were presented as fold-change in 
gene expression in stimulated cells relative to unstimulated controls. Clear bars (unstimulated controls), hatched bars 
(Hz) and filled bars (sHz).  ** indicates statistical significance; p < 0.01, and * indicates statistical significance; p < 
0.05 compared to non-stimulated controls. 
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 CHAPTER 5 
5.0 Discussion 
5.1. Profile of β-Chemokines in Children with Malaria  
We show here that acute falciparum malaria in Gabonese children is characterized by differential 
regulation of β-chemokines in which circulating levels of MIP-1α and MIP-1β are elevated and 
RANTES is reduced.  Analysis of gene expression profiles revealed that altered patterns of 
circulating β-chemokines during different states of disease occur, at least in part, through 
changes in PBMC β-chemokine transcripts levels.  Additional results demonstrated that healthy, 
malaria-exposed children with a history of severe malaria have significantly lower circulating 
levels of RANTES than children with previous mild malaria, suggesting that children who 
develop severe disease may have an inherent inability to produce elevated levels of RANTES.  
Experiments conducted in PBMCs from healthy, malaria-naïve adult donors further revealed that 
co-culture of Hz with monocytes/macrophages in PBMC elicits dysregulation in β-chemokine 
mRNA and protein.      
The role of chemokines in the regulation of host-parasite interactions appears to be highly 
variable in protozoan infections (28).  Chemokines have been shown to have direct antiprotozoal 
activity against Toxoplasma gondi, Leishmania donovani, and Trypanosoma cruzi (28).  
Although the ability of chemokines to regulate intraerythrocytic growth of the malaria parasite 
has not been reported, a functional role for altered expression patterns of chemokines during 
malaria has been associated with mononuclear cell infiltration during placental malaria (29, 30).  
In addition, increased expression of chemokines has been shown in both murine and human 
cerebral malaria (86, 87).  Previous results also showed that serum concentrations of MIP-1α are 
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elevated in adults with P. falciparum malaria in Southeast Asia; levels of MIP-1α were highest 
on day 14 after admission and following treatment (32).  Our studies show that MIP-1α is also 
elevated in children with acute falciparum malaria prior to treatment with antipyretics and/or 
antimalarials, demonstrating that elevated circulating concentrations of MIP-1α are the direct 
result of a malaria infection and are not due solely to treatment interventions.  Analysis of MIP-
1α transcripts in ex vivo PBMC illustrated that MIP-1α gene expression was greater than 50% 
higher in children with malaria than in their healthy, age-matched controls.  These results suggest 
that changes in MIP-1α during acute disease occur, at least in part, through enhanced MIP-1α 
mRNA transcription in PBMC.  Investigation of MIP-1β revealed similar results in which acute 
malaria was characterized by elevated circulating levels of MIP-1β that appear to result from 
malaria-induced up-regulation of MIP-1β gene expression in PBMCs.   
Currently, it is not clear whether increased circulating levels of MIP-1α and MIP-1β in 
acute malaria are an appropriate physiologic response to the infection or if they contribute to 
enhanced pathophysiology.  The previous observation that MIP-1α and IL-8 are induced in the 
acute phase of malaria and remain elevated even after parasite clearance (32), suggests that the 
immunologic effects of chemokines may occur over prolonged periods.  Since a number of 
studies have shown that MIP-1α suppresses hematopoiesis (44, 88-92), sustained elevated levels 
of MIP-1α may contribute to malarial anemia.  Evidence showing that enhanced MIP-1β 
production from bone marrow aspirates is associated with decreased hemoglobin concentrations 
in HIV positive adults subjects, further supports a potential role of chemokines in the promotion 
of anemia (93).  However, results presented here do not support the premise that increased MIP-
1α and MIP-1β during malaria promote anemia.  It is important to note that disease severity in 
the present study was defined according to both parasitemia and anemia status.  Thus, with 
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disease severity based on these two parameters, it may not be possible to fully elucidate the 
contribution of MIP-1α and MIP-1β to the etiology of malarial anemia.  We are currently 
investigating the role of MIP-1α and MIP-1β in the promotion of malarial anemia in a pediatric 
population in western Kenya in which the primary clinical manifestation of severe malaria is 
defined by severe anemia.              
Of particular interest in the current study was the finding that RANTES is suppressed in 
children with severe malaria at both the mRNA and protein level.  There is growing evidence 
that RANTES provides protection against protozoan diseases (94-96).  Although the molecular 
basis of this protection remains unclear, it may be related to bridging innate and adaptive 
immune responses, since RANTES is a specific chemoattractant for memory T cells, and 
augments polarization of a T helper 1 (Th1) response (97).  Thus, in the context of malaria, 
reduced RANTES production may lead to an ineffective immunologic response.  This hypothesis 
is supported by the fact that immunosuppression is a prominent feature of malaria, as evidenced 
by increased susceptibility to a number of bacterial and viral infections, including Salmonellosis 
(98), and reactivation of chronic and latent Herpes zoster (99), Herpes simplex (100) and 
Epstein–Barr virus (101, 102).  Data presented here showing that circulating levels of RANTES 
are significantly reduced in healthy children with a history of severe malaria relative to those that 
previously experienced mild malaria suggests that elevated levels of RANTES may provide 
protection against severe disease.  Interestingly, transcriptional analysis of RANTES revealed 
that children with PSM had significantly higher RANTES mRNA expression than those with 
PMM.  Additional experiments are required to determine if there is an inherent deficiency in 
RANTES transcript stability and/or post-translational modifications that lead to high levels of 
RANTES message, but low levels of circulating protein in children with PSM.  
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Although a number of parasite-derived factors, such as glycosylphospatidylinositols, 
soluble antigens, and Hz, could account for alteration of β-chemokine expression, our work 
using PBMCs from healthy, malaria-naïve adults illustrate that malarial pigment appears to be, at 
least in part, responsible for the altered production of β-chemokines by PBMC.  Comparable 
results with a crude Hz preparation and a sHz moiety prepared in a cell-free solution demonstrate 
that the core heme polymer, FP-IX, and not additional parasite-derived molecules, is likely 
responsible for altered β-chemokine mRNA and protein expression.  Another prominent feature 
of the current work is that, unlike many of the previous studies, a physiologically relevant 
concentration of P. falciparum-derived Hz and sHz (34) was used for the in vitro studies.  The 
profile of MIP-1α and MIP-1β mRNA and protein in the in vitro experiments corresponds more 
closely to the results observed in children with acute malaria than the results for RANTES.  For 
example, protein levels of RANTES decreased under baseline conditions by 48 hr, while 
RANTES increased in cells treated with Hz and sHz at the same time points.  Analyses of 
RANTES transcripts, however, revealed that the mRNA declined by 48 hr in culture, suggesting 
that there would be a subsequent decrease in RANTES protein over prolonged periods.  In the 
current studies, in vitro experiments were not conducted beyond 48 hr since there was decreased 
viability in cells treated with Hz and sHz after several days, making the experiments difficult to 
interpret (data not presented).   
Taken together, our results provide the first reported evidence that children with acute 
falciparum malaria have dysregulation of β-chemokines characterized by elevated MIP-1α and 
MIP-1β and decreased RANTES at the mRNA and protein level.  This distinct profile of β-
chemokine expression appears to be an effect of Hz PPIX on PBMC.  Additional studies aimed 
at defining the role of β-chemokines in the promotion of malarial anemia and the impact of 
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decreased RANTES on malaria-induced immunosuppression may provide important information 
about the pathophysiology of malaria.  
 
5.2. Modulation of CD4 and Chemokine Receptors by Hemozoin 
Our results show that the P. falciparum-derived product, Hz and sHz modulate expression of 
CD4, CCR5 and CXCR4 both at the protein and transcript level in human PBMCs. Hz and sHz 
also exerted a differential effect on the pattern of surface expression of these receptors on 
monocyte and lymphocyte subsets, implying that there are cell-specific effects of malarial 
pigment. In addition, malarial pigment-induced patterns of expression of these surface molecules 
appear, at least in part, to influence susceptibility of human mononuclear cells to infection with 
M-tropic strains of HIV-1.  
Despite growing epidemiological evidence supporting an interaction between malaria and 
HIV infection, limited data exist that define the underlying biological interactions during co-
infection. Chemokine receptors serve as co-receptors for HIV-1 entry into susceptible cells, and 
their regulation forms a critical determinant of HIV-1 pathogenesis (13). Our study provides 
evidence for changes in the regulation of CD4, CCR5 and CXCR4 expression by malaria 
parasite-derived products, and suggests a potential mechanism by which malaria can impact on 
HIV infection.  The pattern of expression of CCR5 and CXCR4 in this study is consistent with 
previously reported findings with soluble P. falciparum-derived antigens (79). Similarly, in the 
context of placental malaria, accumulation of Hz in placental macrophages enhances CCR5 
mRNA expression (103). In our study, however, increased CCR5 mRNA expression did not 
correlate with surface expression of CCR5 on monocytes. A possible explanation for this 
discordance is receptor-ligand mediated internalization.  CCR5 undergoes rapid internalization 
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and recycling following interaction with β-chemokines; MIP-1α, MIP-1β and RANTES (104). 
Our group, as well as others have shown that stimulation of human mononuclear cells with Hz 
induces secretion of β-chemokines, the primary ligands for CCR5 (38, 105).  The precise 
mechanism by which Hz and sHz modulates cellular expression of CCR5 is remains unclear but 
may be through a TNF-α-mediated mechanism (106). TNF-1α acts via p80 type II TNF receptor 
(TNFR2) to induce NF- B with resultant enhanced secretion of MIP-1α, MIP-1β and RANTES 
which directly down-regulates CCR5.  The similar pattern in expression observed with Hz and 
sHz stimulation indicate that the polymerized iron core structure, ferriprotoporphorin (FP)-IX 
may mediate these effects.  
The current study also determined the profile of CXCR4 expression. This study 
demonstrated that CXCR4 expression is differentially regulated on CD14+ and CD3+ cell 
subsets, being down-regulated on monocytes and up-regulated on T cell subsets following Hz 
stimulation. CXCR4 is expressed predominantly on naïve subsets of CD4+ T cells (107, 108) and 
serves as a co-receptor for T-tropic HIV-1 strains (109). One potential mechanism for decreased 
surface expression of CXCR4 occurs through interactions with stromal cell derived factor 1 
(SDF-1), the only known ligand, and a factor that that upon binding to the receptor, leads to 
consequent receptor internalization (110). Our previous results showed that stimulation of human 
PBMCs with Hz or sHz failed to induce SDF-1 transcript and protein (data not presented), 
suggesting that this mechanism is not responsible for down-regulation of CXCR4 expression on 
monocytes. It is possible that CXCR4 down-regulation on monocytes observed in our study is 
due to the recently described IFN-γ and/or TNF-α induced down-regulation of the receptor on 
human blood cell subsets (111, 112).  However, enhanced expression of this receptor on T cell 
subsets, reported in the present study, following stimulation with Hz and sHz against a 
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background of undetectable SDF-1 could lead to in vivo selection of T tropic HIV-1 variants in 
malaria/HIV co-infection, with the consequential rapid clinical progression of HIV to AIDS (77, 
113). 
Another critical question that this study addressed is whether modulation of surface 
receptor expression alters susceptibility of human mononuclear cells to HIV-1 infection. Using 
MDMs stimulated with either Hz or sHz, and subsequently infected with M-tropic strain of HIV, 
our preliminary data indicates differential effects of Hz and sHz on HIV-1 replication. Whereas 
sHz enhanced HIV-1 replication, Hz stimulation had an opposite inhibitory effect. A previous 
study performed with soluble P. falciparum-derived soluble antigens showed a similar inhibitory 
effect attributed to IFN-γ−induced suppression of HIV-1 replication (79). More recently, 
enhanced infectivity of human mononuclear cells with HIV-1 has been reported following 
activation with soluble malarial antigens (69). It is possible that these conflicting in vitro 
findings reflect inherent differences in type of malarial products used for cellular stimulation, 
which ultimately determines the nature of the extra-cellular milieu defined by specific patterns of 
cytokines and chemokines which can exert both inhibitory and stimulatory effects on HIV-1 
replication in mononuclear cells.  
In conclusion, our study demonstrates that the malaria-parasite derived product, Hz, 
modulates the expression of CD4, CCR5 and CXCR4, the principal receptors required for the 
initial infection of target cells by HIV-1 and subsequent in vivo dissemination of the virus. 
Further experiments using this model may provide important details about the molecular 
mechanisms responsible for observed effects of malaria on HIV pathogenesis.  
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5.3. Future Perspectives 
The pathogenesis of P. falciparum infection is complex and little is known about underlying 
molecular determinants. This is further obscured by existing interactions between malaria and 
other co-infections such as HIV. It is, however, widely recognized that a delicate balance 
between pro-inflammatory and anti-inflammatory cytokines influence malaria severity (21, 23-
25). Chemokine-chemokine receptor axis, the principal regulator of leukocyte chemotaxis, could 
also play a role in P. falciparum infection. Chemokines induced at local sites of infection creates 
a gradient that results in attraction of immune cells (26). 
A fundamental question that still needs to be defined is the functional role of circulating 
levels of chemokines in malaria. Our study has shown that CC-chemokines namely, MIP-1α, 
MIP-1β and RANTES are differentially modulated in children with acute P. falciparum malaria. 
However, no association was established with either parasitemia or hemoglobin concentrations. 
Induced MIP-1α and MIP-1β could potentially promote severe malaria anemia by via inhibitory 
effect on development and differentiation of hematopoeitic stem cells (HSCs) (44).  Additional 
studies are required to define the functional relevance of MIP-1α and MIP-1β with respect to 
anemia particularly in settings where severe malaria anemia is the predominant clinical outcome. 
Further, persistent high levels of MIP-1α and MIP-1β even after parasite clearance (32) could 
lead to heightened state of in vivo cellular activation, and facilitate HIV-1 replication in malaria-
HIV co-infected individuals (114). In addition, circulating levels of chemokines could also 
influence HIV pathogenesis via competitive receptor binding or through regulation of HIV 
replication (115).  
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In attempt to define interaction between HIV and malaria examined modulation 
chemokine receptors HIV and chemokines, this study has demonstrated modulation of 
expression of CD4, CCR5 and CXCR4 by Hz and sHz. An essential question that still needs to 
be addressed is the mechanism by which this modulatory effect is exerted. It could be either a 
direct effect of the pigment or an indirect effect mediated by soluble factors released upon 
cellular stimulation with the pigment. Cytokine have been shown to differentially regulate 
expression of chemokine receptors on human peripheral blood cells (PBLs). For example, TNF-
α, IL-4 and IL-3 reduce surface expression of CD4, CCR5 and CXCR4 on human macrophages 
correlates which correlates with reduced HIV-1 infectivity (106, 116, 117). IL-10 enhances 
expression of CCR5 on human macrophages (118) while IL-12, on the other hand, inhibits its 
expression on T cells (118).  IFN-γ and IL-6 have been shown to enhance CXCR4 (119).  
 Another unexpected finding in this study is the differential effect of Hz and sHz on HIV 
replication in MDMs. There is considerable structural similarity between Hz and sHz in terms of 
organization of the core iron constituent. However, Hz has in addition, has lipids, proteins, and 
nucleic acids which are associated with the polymerized iron core structure, ferriprotoporphorin 
(FP)-IX.  It is probably that these subtle structural differences may account for the observed 
different effects of Hz and sHz on HIV-1 replication. Given that Hz and sHz induced similar 
profile of chemokines, CD4 and chemokine receptor expression, post-entry regulatatory 
mechanisms may account for the differences. A previous study showed a dichotomous effect of 
soluble malaria antigen in which stimulation of PBMCs resulted in modulation of expression of 
chemokine receptors with no corresponding increase in HIV-1 infectivity (79). This effect was 
shown to be IFN-γ-mediated. It is Possible that different cytokines induced by Hz and sHz could 
account for the differential effects of these molecules on HIV-1 replication.  It is therefore, 
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apparent that relative balance of cytokines in circulation induced by an infectious agent such as 
P. falciparum potentially has an effect on HIV pathogenesis. With regards to malaria in children, 
cytokine profile characterized by overproduction of TNF-α and lower IL-10/IL-12 ratio is 
associated with severe disease (18). It remains to be determined if such a profile has any impact 
on HIV pathogenesis in malaria-HIV co-infected children 
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Figure 9.  Proposed Model for Interaction of Malaria and HIV-1. 
Potential mechanisms by which hemozoin (Hz) stimulation of human monocytes regulates HIV-1 replication. (1) 
Ingestion of Hz by monocytes induces secretion of IL-10 and TNF-α. A low ratio of IL-10 to TNF-α may be 
associated with increased HIV-1 replication in monocytes. (2) Hemozoin-induced secretion of TNF-α may increase 
surface expression of CD4, CCR5 and CXCR4 on monocytes, and CXCR4 expression on CD4+ T cells, significantly 
increasing the proportion of cellular targets for HIV-1. In contrast, hemozoin-induced secretion of β-chemokines, 
MIP-1α and MIP-1β, the natural ligands for CCR5, may inhibit initial entry and intracellular replication of R5 HIV-
1 strains.  Up-regulation of CXCR4 on T cells in the absence of absence of induction of SDF-1 secretion may 
promote selection of X4 HIV-1 strains, and consequently rapid clinical progression. The relative balance between 
chemokine levels and expression of chemokine receptors may thus determine the overall effect of hemozoin on 
HIV-1 infection.  
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Based on the findings of this study and previously reported work, the proposed model for 
malaria-HIV interaction is illustrated in figure 9. Ingestion of Hz by monocytes induces secretion 
of IL-10 and TNF-α. A low ratio of IL-10 to TNF-α reported in children with severe malaria 
(18) may be associated with increased HIV-1 replication in monocytes. Hz-induced secretion of 
TNF-α may increase surface expression of CD4, CCR5 and CXCR4 on monocytes, and CXCR4 
expression on CD4+ T cells, significantly increasing the proportion of cellular targets for HIV-1. 
In contrast, Hz-induced secretion of β-chemokines, MIP-1α and MIP-1β, natural ligands for 
CCR5, may inhibit initial entry and intracellular replication of R5 HIV-1 strains.  Up-regulation 
of CXCR4 on T cells in the absence of induction of SDF-1 secretion may promote selection of 
X4 HIV-1 strains, and consequently rapid clinical progression. The overall effect of malaria on 
HIV may therefore depend, to a large extent, on nature of soluble factors induced by P. 
falciparum infection, which in turn may exert enhancing and/or inhibitory effect on HIV-1 
replication.  
 44
BIBLIOGRAPHY 
 
1. World Health Organization. 1997. World Malaria Situation in 1994. Weekly 
Epidemiologic Record 72:269. 
 
2. Breman, J. G., A. Egan, and G. T. Keusch. 2001. The intolerable burden of malaria: a 
new look at the numbers. Am J Trop Med Hyg 64:iv. 
 
3. Nosten, F., S. J. Rogerson, J. G. Beeson, R. McGready, T. K. Mutabingwa, and B. 
Brabin. 2004. Malaria in pregnancy and the endemicity spectrum: what can we learn? 
Trends Parasitol 20:425. 
 
4. Mendis, K., B. J. Sina, P. Marchesini, and R. Carter. 2001. The neglected burden of 
Plasmodium vivax malaria. Am J Trop Med Hyg 64:97. 
 
5. Miller, L. H., D. I. Baruch, K. Marsh, and O. K. Doumbo. 2002. The pathogenic basis of 
malaria. Nature 415:673. 
 
6. Maitland, K., M. Makanga, and T. N. Williams. 2004. Falciparum malaria: current 
therapeutic challenges. Curr Opin Infect Dis 17:405. 
 
7. Webster, D., and A. V. Hill. 2003. Progress with new malaria vaccines. Bull World 
Health Organ 81:902. 
 
8. Maxwell, C. A., E. Msuya, M. Sudi, K. J. Njunwa, I. A. Carneiro, and C. F. Curtis. 2002. 
Effect of community-wide use of insecticide-treated nets for 3-4 years on malarial 
morbidity in Tanzania. Trop Med Int Health 7:1003. 
 
9. Howard, S. C., J. Omumbo, C. Nevill, E. S. Some, C. A. Donnelly, and R. W. Snow. 
2000. Evidence for a mass community effect of insecticide-treated bednets on the 
incidence of malaria on the Kenyan coast. Trans R Soc Trop Med Hyg 94:357. 
 
10. Chandramohan, D., and B. M. Greenwood. 1998. Is there an interaction between human 
immunodeficiency virus and Plasmodium falciparum? Int J Epidemiol 27:296. 
 
11. UNAIDS. 2002. Report on the global HIV/AIDS epidemic. Geneva. 
 
12. Krogstad, P. 2003. Molecular biology of the human immunodeficiency virus: current 
and future targets for intervention. Semin Pediatr Infect Dis 14:258. 
 
13. Berger, E. A., P. M. Murphy, and J. M. Farber. 1999. Chemokine receptors as HIV-1 
coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 17:657. 
 
14. Levy, J. A. 1993. Features of human immunodeficiency virus infection and disease. 
Pediatr Res 33:S63. 
 45
 
15. Lewis, D. A. 2003. Antiretroviral combination therapy for HIV infection. Dent Update 
30:242. 
 
16. Lemckert, A. A., J. Goudsmit, and D. H. Barouch. 2004. Challenges in the search for an 
HIV vaccine. Eur J Epidemiol 19:513. 
 
17. Maitland, K., P. Bejon, and C. R. Newton. 2003. Malaria. Curr Opin Infect Dis 16:389. 
 
18. Perkins, D. J., J. B. Weinberg, and P. G. Kremsner. 2000. Reduced interleukin-12 and 
transforming growth factor-beta1 in severe childhood malaria: relationship of cytokine 
balance with disease severity. J Infect Dis 182:988. 
 
19. Othoro, C., A. Lal, B. Nahlen, D. Koech, A. Orago, and V. Udhayakumar. 1999. A low 
interleukin-10 tumor necrosis factor-α ratio is associated with malaria anemia in children 
residing in a holoendemic region in western Kenya. J.  Infect  Dis 179:279. 
 
20. Torre, D., F. Speranza, M. Giola, A. Matteelli, R. Tambini, and G. Biondi. 2002. Role of 
Th1 and Th2 cytokines in immune response to uncomplicated Plasmodium falciparum 
malaria. Clin Diagn Lab Immunol 9:348. 
 
21. Dodoo, D., F. M. Omer, J. Todd, B. D. Akanmori, K. A. Koram, and E. M. Riley. 2002. 
Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production 
in vitro predict clinical immunity to Plasmodium falciparum malaria. J Infect Dis 
185:971. 
 
22. Chaiyaroj, S. C., A. S. Rutta, K. Muenthaisong, P. Watkins, M. Na Ubol, and S. 
Looareesuwan. 2004. Reduced levels of transforming growth factor-beta1, interleukin-12 
and increased migration inhibitory factor are associated with severe malaria. Acta Trop 
89:319. 
 
23. Winkler, S., M. Willheim, K. Baier, D. Schmid, A. Aichelburg, W. Graninger, and P. G. 
Kremsner. 1998. Reciprocal regulation of Th1- and Th2-cytokine-producing T cells 
during clearance of parasitemia in Plasmodium falciparum malaria. Infect Immun 
66:6040. 
 
24. Malaguarnera, L., R. M. Imbesi, S. Pignatelli, J. Simpore, M. Malaguarnera, and S. 
Musumeci. 2002. Increased levels of interleukin-12 in Plasmodium falciparum malaria: 
correlation with the severity of disease. Parasite Immunol 24:387. 
 
25. Musumeci, M., L. Malaguarnera, J. Simpore, A. Messina, and S. Musumeci. 2003. 
Modulation of immune response in Plasmodium falciparum malaria: role of IL-12, IL-18 
and TGF-beta. Cytokine 21:172. 
 
26. Luster, A. D. 2002. The role of chemokines in linking innate and adaptive immunity. 
Curr Opin Immunol 14:129. 
 46
 
27. Bacon, K., M. Baggiolini, H. Broxmeyer, R. Horuk, I. Lindley, A. Mantovani, K. 
Maysushima, P. Murphy, H. Nomiyama, J. Oppenheim, A. Rot, T. Schall, M. Tsang, R. 
Thorpe, J. Van Damme, M. Wadhwa, O. Yoshie, A. Zlotnik, and K. Zoon. 2002. 
Chemokine/chemokine receptor nomenclature. J Interferon Cytokine Res 22:1067. 
 
28. Brenier-Pinchart, M. P., H. Pelloux, D. Derouich-Guergour, and P. Ambroise-Thomas. 
2001. Chemokines in host-protozoan-parasite interactions. Trends Parasitol 17:292. 
 
29. Abrams, E. T., H. Brown, S. W. Chensue, G. D. Turner, E. Tadesse, V. M. Lema, M. E. 
Molyneux, R. Rochford, S. R. Meshnick, and S. J. Rogerson. 2003. Host response to 
malaria during pregnancy: placental monocyte recruitment is associated with elevated 
beta chemokine expression. J Immunol 170:2759. 
 
30. Suguitan, A. L., Jr., R. G. Leke, G. Fouda, A. Zhou, L. Thuita, S. Metenou, J. Fogako, 
R. Megnekou, and D. W. Taylor. 2003. Changes in the levels of chemokines and 
cytokines in the placentas of women with Plasmodium falciparum malaria. J Infect Dis 
188:1074. 
 
31. Chaisavaneeyakorn, S., J. M. Moore, L. Mirel, C. Othoro, J. Otieno, S. C. Chaiyaroj, Y. 
P. Shi, B. L. Nahlen, A. A. Lal, and V. Udhayakumar. 2003. Levels of macrophage 
inflammatory protein 1 alpha (MIP-1 alpha) and MIP-1 beta in intervillous blood plasma 
samples from women with placental malaria and human immunodeficiency virus 
infection. Clin Diagn Lab Immunol 10:631. 
 
32. Burgmann, H., U. Hollenstein, C. Wenisch, F. Thalhammer, S. Looareesuwan, and W. 
Graninger. 1995. Serum concentrations of MIP-1 alpha and interleukin-8 in patients 
suffering from acute Plasmodium falciparum malaria. Clin Immunol Immunopathol 
76:32. 
 
33. Keller, C. C., P. G. Kremsner, J. B. Hittner, M. A. Misukonis, J. B. Weinberg, and D. J. 
Perkins. 2004. Elevated nitric oxide production in children with malarial anemia: 
hemozoin-induced nitric oxide synthase type 2 transcripts and nitric oxide in blood 
mononuclear cells. Infect Immun 72:4868. 
 
34. Keller, C. C., J. B. Hittner, B. K. Nti, J. B. Weinberg, P. G. Kremsner, and D. J. Perkins. 
2004. Reduced peripheral PGE2 biosynthesis in Plasmodium falciparum malaria occurs 
through hemozoin-induced suppression of blood mononuclear cell cyclooxygenase-2 
gene expression via an interleukin-10-independent mechanism. Mol Med 10:45. 
 
35. Francis, S. E., D. J. Sullivan, Jr., and D. E. Goldberg. 1997. Hemoglobin metabolism in 
the malaria parasite Plasmodium falciparum. Annu Rev Microbiol 51:97. 
 
36. Goldie, P., E. Roth Jr, J. Oppenheim, and J. Vanderberg. 1990. Biochemical 
characterization of Plasmodium falciparum hemozoin. Am J Trop Med Hyg 43:584. 
 
 47
37. Egan, T. J., W. W. Mavuso, and K. K. Ncokazi. 2001. The mechanism of beta-hematin 
formation in acetate solution. Parallels between hemozoin formation and 
biomineralization processes. Biochemistry 40:204. 
 
38. Sherry, B. A., G. Alava, K. J. Tracey, J. Martiney, A. Cerami, and A. F. Slater. 1995. 
Malaria-specific metabolite hemozoin mediates the release of several potent endogenous 
pyrogens (TNF, MIP-1 alpha, and MIP-1 beta) in vitro, and altered thermoregulation in 
vivo. J Inflamm 45:85. 
 
39. Pichyangkul, S., P. Saengkrai, and H. Webster. 1994. Plasmodium falciparum pigment 
induces monocytes to release high levels of tumor necrosis factor-α and interleukin-1β. 
American Journal of Tropical Medicine and Hygiene 51:430. 
 
40. Scorza, T., S. Magez, L. Brys, and P. De Baetselier. 1999. Hemozoin is a key factor in 
the induction of malaria-associated immunosuppression. Parasite Immunol 21:545. 
 
41. Schwarzer, E., M. Alessio, D. Ulliers, and P. Arese. 1998. Phagocytosis of the malarial 
pigment, hemozoin, impairs expression of major histocompatibility complex class II 
antigen, CD54, and CD11c in human monocytes. Infect Immun 66:1601. 
 
42. Jaramillo, M., I. Plante, N. Ouellet, K. Vandal, P. A. Tessier, and M. Olivier. 2004. 
Hemozoin-inducible proinflammatory events in vivo: potential role in malaria infection. J 
Immunol 172:3101. 
 
43. Lillard, J. W., Jr., U. P. Singh, P. N. Boyaka, S. Singh, D. D. Taub, and J. R. McGhee. 
2003. MIP-1alpha and MIP-1beta differentially mediate mucosal and systemic adaptive 
immunity. Blood 101:807. 
 
44. Broxmeyer, H. E. 2001. Regulation of hematopoiesis by chemokine family members. Int 
J Hematol 74:9. 
 
45. Snow, R. W., J. A. Omumbo, B. Lowe, C. S. Molyneux, J. O. Obiero, A. Palmer, M. W. 
Weber, M. Pinder, B. Nahlen, C. Obonyo, C. Newbold, S. Gupta, and K. Marsh. 1997. 
Relation Between Severe Malaria Morbidity In Children and Level Of Plasmodium 
Falciparum Transmission In Africa. Lancet 349:1650. 
 
46. Snow, R. W., M. Craig, U. Deichmann, and K. Marsh. 1999. Estimating mortality, 
morbidity and disability due to malaria among Africa's non-pregnant population. Bull 
World Health Organ 77:624. 
 
47. Colebunders, R., Y. Bahwe, W. Nekwei, R. Ryder, J. Perriens, K. Nsimba, A. Turner, H. 
Francis, I. Lebughe, P. Van der Stuyft, and et al. 1990. Incidence of malaria and efficacy 
of oral quinine in patients recently infected with human immunodeficiency virus in 
Kinshasa, Zaire. J Infect 21:167. 
 
 48
48. Greenberg, A. E., W. Nsa, R. W. Ryder, M. Medi, M. Nzeza, N. Kitadi, M. Baangi, N. 
Malanda, F. Davachi, and S. E. Hassig. 1991. Plasmodium falciparum malaria and 
perinatally acquired human immunodeficiency virus type 1 infection in Kinshasa, Zaire. 
A prospective, longitudinal cohort study of 587 children. N Engl J Med 325:105. 
 
49. Taha, T. E., J. K. Canner, G. A. Dallabetta, J. D. Chiphangwi, G. Liomba, A. M. 
Wangel, A. J. Saah, and P. G. Miotti. 1994. Childhood malaria parasitaemia and human 
immunodeficiency virus infection in Malawi. Trans R Soc Trop Med Hyg 88:164. 
 
50. French, N., J. Nakiyingi, E. Lugada, C. Watera, J. A. Whitworth, and C. F. Gilks. 2001. 
Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected 
Ugandan adults.AIDS 15:899. 
 
51. Whitworth, J., D. Morgan, M. Quigley, A. Smith, B. Mayanja, H. Eotu, N. Omoding, M. 
Okongo, S. Malamba, and A. Ojwiya. 2000. Effect of HIV-1 and increasing 
immunosuppression on malaria parasitaemia and clinical episodes in adults in rural 
Uganda: a cohort study. Lancet 356:1051. 
 
52. Francesconi, P., M. Fabiani, M. G. Dente, M. Lukwiya, R. Okwey, J. Ouma, R. 
Ochakachon, F. Cian, and S. Declich. 2001. HIV, malaria parasites, and acute febrile 
episodes in Ugandan adults: a case-control study. AIDS 15:2445. 
 
53. Grimwade, K., N. French, D. D. Mbatha, D. D. Zungu, M. Dedicoat, and C. F. Gilks. 
2004. HIV infection as a cofactor for severe falciparum malaria in adults living in a 
region of unstable malaria transmission in South Africa. AIDS 18:547. 
 
54. Verhoeff, F. H., B. J. Brabin, C. A. Hart, L. Chimsuku, P. Kazembe, and R. L. 
Broadhead. 1999. Increased prevalence of malaria in HIV-infected pregnant women and 
its implications for malaria control. Trop Med Int Health 4:5. 
 
55. van Eijk, A. M., J. G. Ayisi, F. O. ter Kuile, A. Misore, J. A. Otieno, M. S. Kolczak, P. 
A. Kager, R. W. Steketee, and B. L. Nahlen. 2001. Human immunodeficiency virus 
seropositivity and malaria as risk factors for third-trimester anemia in asymptomatic 
pregnant women in western Kenya. Am J Trop Med Hyg 65:623. 
 
56. Ladner, J., V. Leroy, E. Karita, P. van de Perre, and F. Dabis. 2003. Malaria, HIV and 
pregnancy. AIDS 17:275. 
 
57. Ayisi, J. G., A. M. van Eijk, F. O. ter Kuile, M. S. Kolczak, J. A. Otieno, A. O. Misore, 
P. A. Kager, R. W. Steketee, and B. L. Nahlen. 2003. The effect of dual infection with 
HIV and malaria on pregnancy outcome in western Kenya. AIDS 17:585. 
 
58. Mount, A. M., V. Mwapasa, S. R. Elliott, J. G. Beeson, E. Tadesse, V. M. Lema, M. E. 
Molyneux, S. R. Meshnick, and S. J. Rogerson. 2004. Impairment of humoral immunity 
to Plasmodium falciparum malaria in pregnancy by HIV infection. Lancet 363:1860. 
 
 49
59. Moore, J. M., J. Ayisi, B. L. Nahlen, A. Misore, A. A. Lal, and V. Udhayakumar. 2000. 
Immunity to placental malaria. II. Placental antigen-specific cytokine responses are 
impaired in human immunodeficiency virus-infected women. J Infect Dis 182:960. 
 
60. Villamor, E., M. R. Fataki, R. L. Mbise, and W. W. Fawzi. 2003. Malaria parasitaemia 
in relation to HIV status and vitamin A supplementation among pre-school children. Trop 
Med Int Health 8:1051. 
 
61. Rogerson, S. R., M. Gladstone, M. Callaghan, L. Erhart, S. J. Rogerson, E. Borgstein, 
and R. L. Broadhead. 2004. HIV infection among paediatric in-patients in Blantyre, 
Malawi. Trans R Soc Trop Med Hyg 98:544. 
 
62. Hoffman, I. F., C. S. Jere, T. E. Taylor, P. Munthali, J. R. Dyer, J. J. Wirima, S. J. 
Rogerson, N. Kumwenda, J. J. Eron, S. A. Fiscus, H. Chakraborty, T. E. Taha, M. S. 
Cohen, and M. E. Molyneux. 1999. The effect of Plasmodium falciparum malaria on 
HIV-1 RNA blood plasma concentration. AIDS 13:487. 
 
63. Kapiga, S. H., H. Bang, D. Spiegelman, G. I. Msamanga, J. Coley, D. J. Hunter, and W. 
W. Fawzi. 2002. Correlates of plasma HIV-1 RNA viral load among HIV-1-seropositive 
women in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr 30:316. 
 
64. Ayisi, J. G., A. M. van Eijk, R. D. Newman, F. O. ter Kuile, Y. P. Shi, C. Yang, M. S. 
Kolczak, J. A. Otieno, A. O. Misore, P. A. Kager, R. B. Lal, R. W. Steketee, and B. L. 
Nahlen. 2004. Maternal malaria and perinatal HIV transmission, western Kenya. Emerg 
Infect Dis 10:643. 
 
65. Mwapasa, V., S. J. Rogerson, M. E. Molyneux, E. T. Abrams, D. D. Kamwendo, V. M. 
Lema, E. Tadesse, E. Chaluluka, P. E. Wilson, and S. R. Meshnick. 2004. The effect of 
Plasmodium falciparum malaria on peripheral and placental HIV-1 RNA concentrations 
in pregnant Malawian women. AIDS 18:1051. 
 
66. Inion, I., F. Mwanyumba, P. Gaillard, V. Chohan, C. Verhofstede, P. Claeys, K. 
Mandaliya, E. Van Marck, and M. Temmerman. 2003. Placental malaria and perinatal 
transmission of human immunodeficiency virus type 1. J Infect Dis 188:1675. 
 
67. Brahmbhatt, H., G. Kigozi, F. Wabwire-Mangen, D. Serwadda, N. Sewankambo, T. 
Lutalo, M. J. Wawer, C. Abramowsky, D. Sullivan, and R. Gray. 2003. The effects of 
placental malaria on mother-to-child HIV transmission in Rakai, Uganda. AIDS 17:2539. 
 
68. Xiao, L., S. M. Owen, D. L. Rudolph, R. B. Lal, and A. A. Lal. 1998. Plasmodium 
falciparum antigen-induced human immunodeficiency virus type 1 replication is 
mediated through induction of tumor necrosis factor-alpha. J Infect Dis 177:437. 
 
 
 
 
 50
69. Froebel, K., W. Howard, J. R. Schafer, F. Howie, J. Whitworth, P. Kaleebu, A. L. 
Brown, and E. Riley. 2004. Activation by malaria antigens renders mononuclear cells 
susceptible to HIV infection and re-activates replication of endogenous HIV in cells from 
HIV-infected adults. Parasite Immunol 26:213. 
 
70. Freitag, C., C. Chougnet, M. Schito, K. A. Near, G. M. Shearer, C. Li, J. Langhorne, and 
A. Sher. 2001. Malaria infection induces virus expression in human immunodeficiency 
virus transgenic mice by CD4 T cell-dependent immune activation. J Infect Dis 
183:1260. 
 
71. Pisell, T. L., I. F. Hoffman, C. S. Jere, S. B. Ballard, M. E. Molyneux, S. T. Butera, and 
S. D. Lawn. 2002. Immune activation and induction of HIV-1 replication within CD14 
macrophages during acute Plasmodium falciparum malaria coinfection. AIDS 16:1503. 
 
72. Pierson, T. C., and R. W. Doms. 2003. HIV-1 entry and its inhibition. Curr Top 
Microbiol Immunol 281:1. 
 
73. Ono, S. J., T. Nakamura, D. Miyazaki, M. Ohbayashi, M. Dawson, and M. Toda. 2003. 
Chemokines: roles in leukocyte development, trafficking, and effector function. J Allergy 
Clin Immunol 111:1185. 
 
74. Hwang, S. S., T. J. Boyle, H. K. Lyerly, and B. R. Cullen. 1991. Identification of the 
envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 253:71. 
 
75. Shioda, T., J. A. Levy, and C. Cheng-Mayer. 1991. Macrophage and T cell-line tropisms 
of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature 
349:167. 
 
76. Connor, R. I., K. E. Sheridan, D. Ceradini, S. Choe, and N. R. Landau. 1997. Change in 
coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp 
Med 185:621. 
 
77. Bjorndal, A., H. Deng, M. Jansson, J. R. Fiore, C. Colognesi, A. Karlsson, J. Albert, G. 
Scarlatti, D. R. Littman, and E. M. Fenyo. 1997. Coreceptor usage of primary human 
immunodeficiency virus type 1 isolates varies according to biological phenotype. J Virol 
71:7478. 
 
78. Hu, Q. X., A. P. Barry, Z. X. Wang, S. M. Connolly, S. C. Peiper, and M. L. Greenberg. 
2000. Evolution of the human immunodeficiency virus type 1 envelope during infection 
reveals molecular corollaries of specificity for coreceptor utilization and AIDS 
pathogenesis. J Virol 74:11858. 
 
79. Moriuchi, M., H. Moriuchi, H. M. Mon, and H. Kanbara. 2002. Dichotomous effects of 
Plasmodium falciparum antigens on expression of human immunodeficiency virus (HIV) 
coreceptors and on infectability of CD4 cells by HIV. J Infect Dis 186:1194. 
 
 51
 
 
80. Kun, J., R. Schmidt-Ott, L. Lehman, B. Lell, D. Luckner, B. Greve, P. Matousek, and P. 
Kremsner. 1998. Merozoite surface antigen 1 and 2 genotypes and rosetting of 
Plasmodium falciparum in severe and mild malaria in Lambarene, Gabon. Transactions 
of the Royal Society of Tropical Medicine and Hygiene 92:110. 
 
81. Perkins, D. J., P. G. Kremsner, and J. B. Weinberg. 2001. Inverse relationship of plasma 
prostaglandin E2 and blood mononuclear cell cyclooxygenase-2 with disease severity in 
children with Plasmodium falciparum malaria. J Infect Dis 183:113. 
 
82. Weinberg, J. B., J. J. Muscato, and J. E. Niedel. 1981. Monocyte chemotactic peptide 
receptor.  Functional characteristics and ligand-induced regulation. J Clin Invest 68:621. 
 
83. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid 
guanidinium thiocyanate-phenol-chloroform extraction. Analy  Biochem 162:156. 
 
84. Crazzolara, R., K. Johrer, R. W. Johnstone, R. Greil, R. Kofler, B. Meister, and D. 
Bernhard. 2002. Histone deacetylase inhibitors potently repress CXCR4 chemokine 
receptor expression and function in acute lymphoblastic leukaemia. Br J Haematol 
119:965. 
 
85. Luty, A. J., D. J. Perkins, B. Lell, R. Schmidt-Ott, L. G. Lehman, D. Luckner, B. Greve, 
P. Matousek, K. Herbich, D. Schmid, J. B. Weinberg, and P. G. Kremsner. 2000. Low 
interleukin-12 activity in severe Plasmodium falciparum malaria. Infect Immun 68:3909. 
 
86. Hanum, P. S., M. Hayano, and S. Kojima. 2003. Cytokine and chemokine responses in a 
cerebral malaria-susceptible or -resistant strain of mice to Plasmodium berghei ANKA 
infection: early chemokine expression in the brain. Int Immunol 15:633. 
 
87. Sarfo, B. Y., S. Singh, J. W. Lillard, A. Quarshie, R. K. Gyasi, H. Armah, A. A. Adjei, P. 
Jolly, and J. K. Stiles. 2004. The cerebral-malaria-associated expression of RANTES, 
CCR3 and CCR5 in post-mortem tissue samples. Ann Trop Med Parasitol 98:297. 
 
88. Su, S. B., N. Mukaida, J. B. Wang, Y. Zhang, A. Takami, S. Nakao, and K. Matsushima. 
1997. Inhibition of immature erythroid progenitor cell proliferation by macrophage 
inflammatory protein-1-alpha by interacting mainly with a C-C chemokine receptor, 
CCR1. Blood 90:605. 
 
89. Cantor, A. B., and S. H. Orkin. 2002. Transcriptional regulation of erythropoiesis: an 
affair involving multiple partners. Oncogene 21:3368. 
 
90. Lord, B. I., C. M. Heyworth, and L. B. Woolford. 1993. Macrophage inflammatory 
protein: its characteristics, biological properties and role in the regulation of 
haemopoiesis. Int J Hematol 57:197. 
 
 52
91. Graham, G. J., and I. B. Pragnell. 1992. SCI/MIP-1 alpha: a potent stem cell inhibitor 
with potential roles in development. Dev Biol 151:377. 
 
92. Graham, G. J., E. G. Wright, R. Hewick, S. D. Wolpe, N. M. Wilkie, D. Donaldson, S. 
Lorimore, and I. B. Pragnell. 1990. Identification and characterization of an inhibitor of 
haemopoietic stem cell proliferation. Nature 344:442. 
 
93. Dallalio, G., M. North, S. W. McKenzie, and R. T. Means, Jr. 1999. Cytokine and 
cytokine receptor concentrations in bone marrow supernatant from patients with HIV: 
correlation with hematologic parameters. J Investig Med 47:477. 
 
94. Villalta, F., Y. Zhang, K. E. Bibb, J. C. Kappes, and M. F. Lima. 1998. The cysteine-
cysteine family of chemokines RANTES, MIP-1alpha, and MIP-1beta induce 
trypanocidal activity in human macrophages via nitric oxide. Infect Immun 66:4690. 
 
95. Machado, F. S., G. A. Martins, J. C. Aliberti, F. L. Mestriner, F. Q. Cunha, and J. S. 
Silva. 2000. Trypanosoma cruzi-infected cardiomyocytes produce chemokines and 
cytokines that trigger potent nitric oxide-dependent trypanocidal activity. Circulation 
102:3003. 
 
96. Santiago Hda, C., C. F. Oliveira, L. Santiago, F. O. Ferraz, G. de Souza Dda, L. A. de-
Freitas, L. C. Afonso, M. M. Teixeira, R. T. Gazzinelli, and L. Q. Vieira. 2004. 
Involvement of the chemokine RANTES (CCL5) in resistance to experimental infection 
with Leishmania major. Infect Immun 72:4918. 
 
97. Mackay, C. R. 2001. Chemokines: immunology's high impact factors. Nat Immunol 
2:95. 
 
98. Mabey, D. C., A. Brown, and B. M. Greenwood. 1987. Plasmodium falciparum malaria 
and Salmonella infections in Gambian children. J Infect Dis 155:1319. 
 
99. Cook, I. F. 1985. Herpes zoster in children following malaria. J Trop Med Hyg 88:261. 
 
100. Scott, J. G. 1944. Herpes simplex cornea in malaria. British Medical Journal 2:213. 
 
101. Whittle, H. C., J. Brown, K. Marsh, B. M. Greenwood, P. Seidelin, H. Tighe, and L. 
Wedderburn. 1984. T-cell control of Epstein-Barr virus-infected B cells is lost during P. 
falciparum malaria. Nature 312:449. 
 
102. Whittle, H. C., J. Brown, K. Marsh, M. Blackman, O. Jobe, and F. Shenton. 1990. The 
effects of Plasmodium falciparum malaria on immune control of B lymphocytes in 
Gambian children. Clin Exp Immunol 80:213. 
 
103. Tkachuk, A. N., A. M. Moormann, J. A. Poore, R. A. Rochford, S. W. Chensue, V. 
Mwapasa, and S. R. Meshnick. 2001. Malaria enhances expression of CC chemokine 
receptor 5 on placental macrophages. J Infect Dis 183:967. 
 53
 
104. Mueller, A., N. G. Mahmoud, M. C. Goedecke, J. A. McKeating, and P. G. Strange. 
2002. Pharmacological characterization of the chemokine receptor, CCR5. Br J 
Pharmacol 135:1033. 
 
105. Ochiel, D. e. a. 2004. Differential regulation of β-chemokines in children with acute 
falciparum malaria. In press. Infection and Immunity (In press). 
 
106. Hornung, F., G. Scala, and M. J. Lenardo. 2000. TNF-alpha-induced secretion of C-C 
chemokines modulates C-C chemokine receptor 5 expression on peripheral blood 
lymphocytes. J Immunol 164:6180. 
 
107. Rabin, R. L., M. K. Park, F. Liao, R. Swofford, D. Stephany, and J. M. Farber. 1999. 
Chemokine receptor responses on T cells are achieved through regulation of both 
receptor expression and signaling. J Immunol 162:3840. 
 
108. Bleul, C. C., L. J. Wu, J. A. Hoxie, T. A. Springer, and C. R. Mackay. 1997. The HIV 
coreceptors CXCR4 and CCR5  are differentially expressed and regulated on human T 
lymphocytes. Proc Nat  Acad  Sci USA 94:1925. 
 
109. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: 
functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 
272:872. 
 
110. Signoret, N., J. Oldridge, A. Pelchen-Matthews, P. J. Klasse, T. Tran, L. F. Brass, M. M. 
Rosenkilde, T. W. Schwartz, W. Holmes, W. Dallas, M. A. Luther, T. N. Wells, J. A. 
Hoxie, and M. Marsh. 1997. Phorbol esters and SDF-1 induce rapid endocytosis and 
down modulation of the chemokine receptor CXCR4. J Cell Biol 139:651. 
 
111. Bruhl, H., C. D. Cohen, S. Linder, M. Kretzler, D. Schlondorff, and M. Mack. 2003. 
Post-translational and cell type-specific regulation of CXCR4 expression by cytokines. 
Eur J Immunol 33:3028. 
 
112. Shirazi, Y., and P. M. Pitha. 1998. Interferon downregulates CXCR4 (fusin) gene 
expression in peripheral blood mononuclear cells. J Hum Virol 1:69. 
 
113. Connor, R. I., K. E. Sheridan, D. Ceradini, S. Choe, and N. R. Landau. 1997. Change in 
coreceptor use correlates with disease progression in HIV-1--infected individuals. J Exp 
Med 185:621. 
 
114. Lawn, S. D., S. T. Butera, and T. M. Folks. 2001. Contribution of immune activation to 
the pathogenesis and transmission of human immunodeficiency virus type 1 infection. 
Clin Microbiol Rev 14:753. 
 
115. Kinter, A., J. Arthos, C. Cicala, and A. S. Fauci. 2000. Chemokines, cytokines and HIV: 
a complex network of interactions that influence HIV pathogenesis. Immunol Rev 177:88. 
 54
 
116. Wang, J., G. Roderiquez, T. Oravecz, and M. A. Norcross. 1998. Cytokine regulation of 
human immunodeficiency virus type 1 entry and replication in human 
monocytes/macrophages through modulation of CCR5 expression. J Virol 72:7642. 
 
117. Bailer, R. T., B. Lee, and L. J. Montaner. 2000. IL-13 and TNF-alpha inhibit dual-tropic 
HIV-1 in primary macrophages by reduction of surface expression of CD4, chemokine 
receptors CCR5, CXCR4 and post-entry viral gene expression. Eur J Immunol 30:1340. 
 
118. Wang, J., K. Crawford, M. Yuan, H. Wang, P. R. Gorry, and D. Gabuzda. 2002. 
Regulation of CC chemokine receptor 5 and CD4 expression and human 
immunodeficiency virus type 1 replication in human macrophages and microglia by T 
helper type 2 cytokines. J Infect Dis 185:885. 
 
119. Zaitseva, M., S. Lee, C. Lapham, R. Taffs, L. King, T. Romantseva, J. Manischewitz, 
and H. Golding. 2000. Interferon gamma and interleukin 6 modulate the susceptibility of 
macrophages to human immunodeficiency virus type 1 infection. Blood 96:3109. 
 
 55
